Usk Therapeutics Private Limited
Specialty pharmaceutical and nutritional formulations manufacturing company based in Karnataka.
2021 | Bangaluru, Karnataka (India) | Active
Usk Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 211.69%
- Ebitda 255.79%
- Net Worth 274.49%
- Total Assets 441.72%
About Usk Therapeutics
Usk Therapeutics Private Limited (UTPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 September 2021 (Three years and seven months 23 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishna Madakala, Puchalapalli Sankeerthi, Sadu Kameswari, and Two other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290KA2021PTC152293
- Company No.
152293
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Pharma
Usk Therapeutics Private Limited
Explore comprehensive data for Usk Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Usk Therapeutics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sadu Kameswari  | Managing Director | 27-Sep-2021 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishna Madakala | Director | 27-Sep-2021 | Current |
| Puchalapalli Sankeerthi | Director | 27-Sep-2021 | Current |
| Sobha Velamuru | Director | 27-Sep-2021 | Current |
| Katakam Ushasree | Director | 27-Sep-2021 | Current |
Financial Performance of Usk Therapeutics.
Usk Therapeutics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 211.69% increase in profit. The company's net worth Soared by an impressive increase of 274.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Usk Therapeutics?
In 2023, Usk Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Krishnasasi Health Care Private Limited
Ramakrishna Madakala is a mutual person
- Sai Siddartha Super Speciality Hospitals Llp
Katakam Ushasree is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Usk Therapeutics?
Unlock and access historical data on people associated with Usk Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Usk Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usk Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Usk Therapeutics
Recent activity within the organization
- Annual General Meeting
Usk Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Usk Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Director Appointment
Ramakrishna Reddy Madakala was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 3 years 7 months .
- Director Appointment
Puchalapalli Sankeerthi was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 3 years 7 months .
- Director Appointment
Sadu Kameswari was appointed as a Managing Director was appointed as a Managing Director on 27 Sep 2021 & has been associated with this company since 3 years 7 months .
- Director Appointment
Sobha Velamuru was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 3 years 7 months .
Frequently asked questions
What is the Incorporation or founding date of Usk Therapeutics Private Limited?
Usk Therapeutics Private Limited was incorporated on 27 Sep 2021.
What is authorized share capital and paid-up capital of Usk Therapeutics Private Limited?
The authorized share capital of Usk Therapeutics Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Usk Therapeutics Private Limited?
Currently 5 directors are associated with Usk Therapeutics Private Limited.
- Ramakrishna Reddy Madakala
- Puchalapalli Sankeerthi
- Sadu Kameswari
- Sobha Velamuru
- Katakam Ushasree
What is the registered address of Usk Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Usk Therapeutics Private Limited is Flat No 102 1St Floor Sv Elegant Syno.2/1 2/7 Kumbena Agrahara, Belathur India, Kadugodi, Karnataka, 560067.
What is the corporate identification number (CIN) and company number of Usk Therapeutics Private Limited?
The corporate identification number (CIN) of Usk Therapeutics Private Limited is U24290KA2021PTC152293 and the company number is 152293 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Usk Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Usk Therapeutics Private Limited has experienced an upsurge of 274.49%.
When was the last Balance Sheet of Usk Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Usk Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records